← Leaderboards
Fraser James Sim
State University Of New York At Buffalo
$3,430,826
Attributed
$4,333,927
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $978.3K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,333,927 · 4
By mechanism
R01$4,333,927 · 4
Top collaborators
- Stelios Theoharis Andreadis5 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Stelios Theoharis Andreadis$16,967,670
- Daesung Shin$2,365,315
- Nadav Weinstock$143,162
- Randolph Lee Carter$219,313
- Narayan Dhimal$62,490
Others in their field
Other Emerging Leaders on “Demyelinations”
- Dimitry N Krementsov · University Of Vermont & St Agric College$3,872,525
- David Pitt · Yale University$3,508,498
- Deqiang Qiu · Emory University$3,221,061
- Daniel Ontaneda · Cleveland Clinic Lerner Com-Cwru$2,994,181
- Stephen Philip James Fancy · University Of California, San Francisco$2,932,733
- Susan A Gauthier · Weill Medical Coll Of Cornell Univ$2,825,951
Research focus
DemyelinationsMyelinDemyelinating DiseasesRepairedRemyelinationOligodendrogliaPreventTransplantationMultiple SclerosisMyelinationMediatingRegenerative TherapyRodentCellsCell TypeNeurodegenerative DisordersAnimal ModelLaboratoriesCell Differentiation ProcessCell DeathInflammationDesignIn VivoNeuroglia
Grant awards (12)
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$574,654
R01 · FY2025 · NS
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$65,403
R01 · FY2025 · NS
Investigation of the effects of interleukin-10 shear thinning hydrogel on human oligodendrocyte progenitor cell survival and differentiation following transplantation$40,812
R01 · FY2025 · NS
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$553,693
R01 · FY2024 · NS
Laminin Receptors and Signals in Schwann Cells$376,510
R01 · FY2024 · NS · contact PI
Programmable Hydrogels for Optimized Human Oligodendrocyte Transplantation in Demyelinating Disease$571,641
R01 · FY2023 · NS
The Peripheral Nervous System: A Window into Krabbe Disease$406,684
R01 · FY2023 · NS · contact PI
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation$348,906
R01 · FY2022 · NS · contact PI
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation$348,906
R01 · FY2021 · NS · contact PI
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation$348,906
R01 · FY2020 · NS · contact PI
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation$348,906
R01 · FY2019 · NS · contact PI
Muscarinic Receptor Type 3 Regulation of Oligodendrocyte Progenitor Differentiation$348,906
R01 · FY2018 · NS · contact PI